Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SDIX > SEC Filings for SDIX > Form 8-K on 25-Jul-2013All Recent SEC Filings

Show all filings for SPECIAL DIVERSIFIED OPPORTUNITIES INC.

Form 8-K for SPECIAL DIVERSIFIED OPPORTUNITIES INC.


25-Jul-2013

Change in Directors or Principal Officers, Other Events


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously disclosed by Special Diversified Opportunities Inc. (the "Company") on its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on July 15, 2013, Mr. Francis M. DiNuzzo would cease to be employed as the President and Chief Executive Officer of the Company, effective as of a future date as determined by the board of directors of the Company (the "Board"). At a meeting held on July 23, 2013, the Board determined that Mr. DiNuzzo's termination of employment shall be effective as of 5:00 p.m. on July 24, 2013. In addition, Mr. DiNuzzo tendered, and the Board accepted, his resignation from the Board, also to be effective as of 5:00 p.m. on July 24, 2013. As previously disclosed, Mr. DiNuzzo was entitled, among other severance benefits, 12 months of continued monthly base salary. At its July 23, 2013 meeting, the Board agreed to pay this amount in a lump sum promptly after Mr. DiNuzzo's termination of employment.

In addition, C. Geoffrey Davis resigned from the Board effective as of July 23, 2013 and Stephen L. Waechter resigned from the Board effective as of July 24, 2013.

On July 23, 2013, Mr. Phil Blazek, 45, was appointed by the Board as President of the Company (in which capacity he will be the Company's principal executive officer), effective as of Mr. DiNuzzo's termination, to serve until his successor shall be appointed. Mr. Blazek has a broad financial, strategic and investment background working with companies in a range of industries. Prior to joining the Company, in 2012 Mr. Blazek was a Managing Director at Korenvaes Management, a Dallas based debt/equity investment fund. From 2008 through 2011, he was President and Chief Investment Officer of Blazek Crow Holdings Capital, an equity investment fund he founded in partnership with the Crow Holdings Family Office in Dallas, which focused on small cap U.S. companies across several industries. From 2005 to 2008, Mr. Blazek worked at Greenway Capital, investing and providing new capital to small cap companies. Mr. Blazek received a Harvard University AB, 1990; Harvard Business School MBA, 1996.



Item 8.01 Other Events.

Based on preliminary unaudited financial information for the quarter ended June 30, 2013, the Company had cash of $13,993,000 as of June 30, 2013. As of July 12, 2013, and following the closing on that date of the sale of substantially all of the Company's assets related exclusively to the Company's life sciences business, the product portfolio in respect of which includes a full suite of integrated capabilities, including antibody and assay design, development and product and the Advanced Technologies Business (the "Asset Sale"), the Company believes its pro forma cash balance was in the range of $25,750,000 to $26,850,000. This amount reflects pro forma adjustments for estimated closing costs, including all severance amounts, and an estimate of the working capital adjustment as provided for in the Asset Purchase Agreement relating to the Asset Sale. This amount also includes $1,300,000 that remains in escrow pursuant to such Asset Purchase Agreement.

As previously disclosed, the Board will undertake a process to determine the best use of the Company's cash, public company status and remaining assets, including net tax operating losses. At this time, the Board has not made any such determination.

  Add SDIX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SDIX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.